DKNG three-lens brief
Evidence-based stock research on DKNG. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $35.28 — 45% above current (33 analysts). · Trading at 14% of its 52-week range — deep in the lower band.
- Trading at 14% of its 52-week range — deep in the lower band.
- P/E of 271 — priced for high growth; little margin of safety.
- Analyst mean target $35.28 — 45% above current (33 analysts).
- Debt-to-equity of 317.0 — balance-sheet-heavy.
DKNG closed at $24.36 (-1.02%) as of 2026-05-13. Market cap: $12.09B. P/E (trailing) 270.7. Positives: analyst mean target $35.28 — 45% above current (33 analysts).. Concerns: trading at 14% of its 52-week range — deep in the lower band.; p/E of 271 — priced for high growth; little margin of safety.. Last quarter: Revenue $1.65B, net income $21.07M, free cash flow $603.18M.
Why three lenses on DKNG, not one.
A single reasoning model has blind spots it doesn’t know about. We examine DKNGacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/DKNG" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath DKNG brief"></iframe>